The actor who plays Finn, a disillusioned Stormtrooper in the new film, has said he's "a confident, Nigerian, black, chocolate man." Nigerian filmgoers are over the moon.
Even savvy consumers stumble over the meaning of coinsurance and other jargon. The misunderstandings can be costly, especially when picking a health plan.
From big food companies simplifying ingredients, to the U.S. government's new goal to reduce food waste, to a public image crisis for Chipotle, 2015 has been a big year for food.
A Native American family that sees Alzheimer's disease as a natural part of life may be less likely to reach for resources that could help, say Arizona mental health workers. They hope to change that.
In poorly regulated Lahore, Pakistan, Ayesha Mumtaz is a relentless enforcer of food-safety rules who strikes fear into local eatery owners. But some restaurateurs say she goes too far.
When Jimmy Carter said his advanced melanoma was gone, he credited immunotherapy, treatments that harness the immune system to fight cancer cells. This idea dates back to a 19th-century doctor.
A tool for modifying genes is spreading through the biomedical research world like wildfire. As part of the series Joe's Big Idea, NPR's Joe Palca explores why CRISPR-Cas9 is becoming indispensable.
Effective treatments for hepatitis C cost as much as $95,000. Medicaid in many states, including Indiana, is mostly limiting the drugs' use to very advanced cases. ACLU of Indiana is suing the state.
For the first time in decades, the number of children with asthma isn't increasing, federal scientists report. But cases continue to rise among African-American children and poor children.